Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period

Clinical trial NCT03449342 · COMPLETED

Trial details

NCT number: NCT03449342
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Haemophilia A

Start date: 2018-03-01
Primary completion: 2019-03-25
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.